Next, Oncolytics Biotech (ONCY – Free Report) is a company known for developing treatments for deadly viruses as well as cancers. However, it should be mentioned that ONCY may be a bit far off the path of a company working to find a vaccine for coronavirus. The main focus of the company is on cancer. But in your search to find coronavirus stocks, you may come across Oncolytics.
Regardless of its progress in that light, the company does have an active pipeline developing different cancer therapies. Furthermore, Oncolytics has a laundry list of partnerships with larger biotech firms. These include Roche, Pfizer, Merck, and Bristol-Myers Squibb. It’s pipeline includes treatments in numerous clinical phases and in combination with proven drugs. Keytruda, Tecentriq, Opdivo, and Bavencio are all being combined with Oncolytics lead therapy, pelareorep.
So if coronavirus stocks are your focus, Oncolytics may not be “the one.” However, from a cancer stock angle, it may be worth understanding a bit more on its treatment pipeline. Pelareorep has applications for breast cancer treatments, GI cancer treatments, and multiple myeloma treatments right now.
